Showing 1 - 1 results of 1 for search 'L. Bazhenova', query time: 0.01s Refine Results
  1. 1
    BLU-945 Monotherapy and Combination With Osimertinib in Previously Treated Patients With Advanced EGFR-Mutant (EGFRm) NSCLC in Phase 1/2 SYMPHONY Study

    BLU-945 Monotherapy and Combination With Osimertinib in Previously Treated Patients With Advanced EGFR-Mutant (EGFRm) NSCLC in Phase 1/2 SYMPHONY Study by Y. Elamin, M. Nagasaka, E. Shum, L. Bazhenova, J. Rotow, D.R. Spigel, D.S.W. Tan, A. Zalutskaya, F. Albayya, K.L. Reckamp

    Published 2023-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: